Literature DB >> 8543958

Computerised record linkage: compared with traditional patient follow-up methods in clinical trials and illustrated in a prospective epidemiological study. The West of Scotland Coronary Prevention Study Group.

.   

Abstract

Computerised record linkage systems have great potential for enhancing or even replacing traditional methods of adverse event reporting based on active patient follow-up, both in clinical trials and in epidemiological studies. However, these methods must be evaluated. The West of Scotland Coronary Prevention Study (WOSCOPS) is a randomised double-blind clinical trial of pravastatin versus placebo in the primary prevention of coronary heart disease, with coronary heart disease death plus nonfatal myocardial infarction as its primary end point. Adverse event reporting is based on active patient follow-up at routine trial visits. In parallel with this approach, we have obtained computer records of all deaths, incident cancers, and hospitalisations for our subjects by linking their names, dates of birth, and postcodes of their home addresses with a Scottish national database operated by the Scottish Record Linkage system. The results of this comparative study, based on follow-up of the 6595 men ages 45-64 randomised in WOSCOPS, demonstrate minor flaws in both systems, show that follow-up based on computerised linkage alone can be as effective as reporting based on direct contact with the patients, and show that a system based on both approaches provides a direct cross-validation of the two approaches to adverse event reporting while minimising the frequency of unreported events. Preliminary results are reported for a prospective epidemiological study of 80,184 men, ages 45-64 years, who were screened for coronary heart disease risk factors as part of WOSCOPS. This study is based solely on computerised linkage reporting of events on these subjects. This provides an indication of the number of events in various categories that will be available for analysis in future reports. The associations between death rates and standard risk factors such as age, blood pressure, total cholesterol level, and smoking status mirror those reported in other studies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8543958     DOI: 10.1016/0895-4356(95)00530-7

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  37 in total

Review 1.  Balancing benefits and harms: the example of non-steroidal anti-inflammatory drugs.

Authors:  Paul Dieppe; Christopher Bartlett; Peter Davey; Lesley Doyal; Shah Ebrahim
Journal:  BMJ       Date:  2004-07-03

2.  Mortality within 1 year after hip fracture surgical repair in the elderly according to postoperative period: a probabilistic record linkage study in Brazil.

Authors:  E I O Vidal; C M Coeli; R S Pinheiro; K R Camargo
Journal:  Osteoporos Int       Date:  2006-07-27       Impact factor: 4.507

3.  Fasting plasma glucose in non-diabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up.

Authors:  David Preiss; Paul Welsh; Heather M Murray; James Shepherd; Chris Packard; Peter Macfarlane; Stuart Cobbe; Ian Ford; Naveed Sattar
Journal:  Eur Heart J       Date:  2010-04-15       Impact factor: 29.983

4.  Delay from fracture to hospital admission: a new risk factor for hip fracture mortality?

Authors:  E I O Vidal; D C Moreira-Filho; R S Pinheiro; R C Souza; L M Almeida; K R Camargo; P J F Villas Boas; F B Fukushima; C M Coeli
Journal:  Osteoporos Int       Date:  2012-12       Impact factor: 4.507

5.  Comparison between research data and routinely collected register data for studying childhood health.

Authors:  M Gissler; M R Järvelin; E Hemminki
Journal:  Eur J Epidemiol       Date:  2000-01       Impact factor: 8.082

6.  Validity of diagnoses of major coronary events in national registers of hospital diagnoses and deaths in Finland.

Authors:  J M Rapola; J Virtamo; P Korhonen; J Haapakoski; A M Hartman; B K Edwards; O P Heinonen
Journal:  Eur J Epidemiol       Date:  1997-02       Impact factor: 8.082

7.  Inequity of access to investigation and effect on clinical outcomes: prognostic study of coronary angiography for suspected stable angina pectoris.

Authors:  Neha Sekhri; Adam Timmis; Ruoling Chen; Cornelia Junghans; Niamh Walsh; M Justin Zaman; Justin Zaman; Sandra Eldridge; Harry Hemingway; Gene Feder
Journal:  BMJ       Date:  2008-04-24

8.  Diabetes and modifiable risk factors for cardiovascular disease: the prospective Million Women Study.

Authors:  Elizabeth A Spencer; Kirstin L Pirie; Richard J Stevens; Valerie Beral; Anna Brown; Bette Liu; Jane Green; Gillian K Reeves
Journal:  Eur J Epidemiol       Date:  2008-11-18       Impact factor: 8.082

9.  Impact of unlinked deaths and coding changes on mortality trends in the Swiss National Cohort.

Authors:  Kurt Schmidlin; Kerri M Clough-Gorr; Adrian Spoerri; Matthias Egger; Marcel Zwahlen
Journal:  BMC Med Inform Decis Mak       Date:  2013-01-04       Impact factor: 2.796

Review 10.  Realising the full potential of data-enabled trials in the UK: a call for action.

Authors:  Matthew R Sydes; Yolanda Barbachano; Louise Bowman; Tom Denwood; Andrew Farmer; Steph Garfield-Birkbeck; Martin Gibson; Martin C Gulliford; David A Harrison; Catherine Hewitt; Jennifer Logue; Will Navaie; John Norrie; Martin O'Kane; Jennifer K Quint; Jo Rycroft-Malone; Jonathan Sheffield; Liam Smeeth; Frank Sullivan; Juliet Tizzard; Paula Walker; John Wilding; Paula R Williamson; Martin Landray; Andrew Morris; Rhoswyn R Walker; Hywel C Williams; Janet Valentine
Journal:  BMJ Open       Date:  2021-06-16       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.